Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 1.70% | 426.06k | 215.33k |
Vanguard Extended Market Index Fund | 1.10% | 274.61k | 138.79k |
Fidelity Extended Market Index Fund | 0.45% | 111.64k | 56.42k |
iShares Micro Cap ETF | 0.18% | 44.2k | 22.34k |
Fidelity NASDAQ Composite Index Fund | 0.15% | 36.45k | 18.42k |
Fidelity Total Market Index Fund | 0.09% | 22.5k | 11.37k |
Fidelity Series Total Market Index Fund | 0.09% | 21.26k | 10.75k |
Vanguard Institutional Index-Inst Total Stock Market Ind | 0.08% | 19.27k | 9.74k |
Vanguard Balanced Index Fund | 0.02% | 5.06k | 2.56k |
EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 3.41k | 1.72k |
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
06/27 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
06/12 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
05/14 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
04/09 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
03/28 04:05 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
02/06 08:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
12/11 08:30 am
GlobeNewswire Inc.
Read moreDow Jumps Around 200 Points; US Core PCE Inflation Slows In October
11/30 10:42 am
Benzinga
Read moreDow Jumps Over 100 Points; Hormel Foods Earnings Miss Estimates
11/29 03:20 pm
Benzinga
Read moreVivos Therapeutics stock soars as sleep apnea device gets regulatory clearance
11/29 12:09 pm
MarketWatch
Read moreNasdaq Surges Over 100 Points; US Economy Expands Faster Than Expected
11/29 10:48 am
Benzinga
Read moreVivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
11/29 08:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
11/09 05:30 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Closes $4 Million Private Placement
11/02 05:00 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Signs Nationwide Distribution Agreement with Lincare
10/24 07:30 am
GlobeNewswire Inc.
Read moreHere Is Why Bargain Hunters Would Love Fast-paced Mover Vivos Therapeutics, Inc. (VVOS)
10/12 08:50 am
Zacks Investment Research
Read moreVivos Therapeutics to Begin Clinical Trial at Stanford Medicine
10/11 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion
10/05 07:30 am
GlobeNewswire Inc.
Read moreCreating a Profitable Penny Stocks Watchlist
10/05 06:59 am
PennyStocks
Read moreNasdaq Rises 100 Points; RPM International Posts Upbeat Earnings
10/04 02:30 pm
Benzinga
Read moreCrude Oil Falls Sharply; ISM Services PMI Declines In September
10/04 11:59 am
Benzinga
Read moreUS Stocks Rise Following ADP Data; Dow Rises Over 50 Points
10/04 09:44 am
Benzinga
Read moreVivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers
10/04 07:30 am
GlobeNewswire Inc.
Read moreHere's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom Fisher
08/23 09:55 am
Zacks Investment Research
Read moreVivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update
08/16 04:05 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call
08/16 07:30 am
GlobeNewswire Inc.
Read moreVivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call
08/14 05:06 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call
08/10 08:31 pm
GlobeNewswire Inc.
Read moreNasdaq Down Over 100 Points; US Trade Deficit Shrinks In June
08/08 09:50 am
Benzinga
Read moreWhy ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
07/12 08:19 am
Benzinga
Read moreLooking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS)
06/13 08:50 am
Zacks Investment Research
Read moreVivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Tops Revenue Estimates
06/08 05:25 pm
Zacks Investment Research
Read moreVivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update
06/08 04:05 pm
GlobeNewswire Inc.
Read moreVivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call
06/06 04:30 pm
GlobeNewswire Inc.
Read morePhreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
05/31 05:15 pm
Zacks Investment Research
Read moreGain Therapeutics, Inc. (GANX) Reports Q1 Loss, Tops Revenue Estimates
05/12 09:15 am
Zacks Investment Research
Read more